Omega-3/Heart Disease Amended Health Claim Without Disclaimer Proposed
This article was originally published in The Tan Sheet
FDA should amend the approved health claim linking omega-3 fatty acids to a reduced risk of coronary heart disease by removing the disclaimer and extending the claim to foods, supplement industry members maintain in a June 23 petition
You may also be interested in...
FDA's qualified health claim linking omega-3 fatty acids to coronary heart disease too narrowly interprets the beneficial relationship, dietary supplement industry stakeholders contend
Fish oil products and supplements containing omega-3 fatty acids would be exempt from lengthy disclaimers when using qualified coronary heart disease reduction claims, while fish would not, under a proposal submitted to FDA by Martek Biosciences
FDA has filed health claim petition "for conventional foods and dietary supplements relating consumption of omega-3 fatty acids...to reduced risk of coronary heart disease," agency states in Sept. 3 letter to Washington, D.C. law firm Emord & Associates. Emord submitted petition June 23 on behalf of Wellness Lifestyles, Inc., and Life Extension Foundation Buyers Club (1"The Tan Sheet" June 30, 2003, p. 11). Petition is posted on FDA 2website, with open comment period until Nov. 2. Agency will notify petitioners of final decision by April 15, 2004...